About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Study Evaluating Bifeprunox in Patients With Schizophrenia.

Study Evaluating Bifeprunox in Patients With Schizophrenia.

NCT00366327·82 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Wyeth is now a wholly owned subsidiary of Pfizer

Age

18–66

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. Outpatients who have successfully completed Wyeth study 3168A1-313.
2. A signed and dated informed consent form for this study.
3. No major protocol violations in the previous study.

You may not be if

1. Clinically important abnormalities in the preceding short-term study that have not resolved.
2. Use of prohibited treatments in the preceding short-term study.

The record

StatusTerminated

PhasePhase 3

Taking part400

StartedJan 2007

UpdatedFeb 11, 2013

Conditions

Where82

Little Rock, Arkansas, United States
Little Rock, Arkansas, United States
Anaheim, California, United States